1.
Joshua F. Zeidner, Judith E. Karp, Amanda L. Blackford, B. Douglas Smith, Ivana Gojo, Steven D. Gore, Mark J. Levis, Hetty E. Carraway, Jacqueline M. Greer, S. Percy Ivy, Keith W. Pratz, Michael A. McDevitt. A phase II trial of sequential ribonucleotide reductase inhibition in aggressive myeloproliferative neoplasms. haematol [Internet]. 2014Apr.1 [cited 2021Nov.29];99(4):672-8. Available from: https://haematologica.org/article/view/6997